1. Home
  2. FSV vs TVTX Comparison

FSV vs TVTX Comparison

Compare FSV & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSV

FirstService Corporation

N/A

Current Price

$128.44

Market Cap

6.1B

Sector

Finance

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$57.22

Market Cap

5.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSV
TVTX
Founded
1988
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.3B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
FSV
TVTX
Price
$128.44
$57.22
Analyst Decision
Buy
Strong Buy
Analyst Count
10
15
Target Price
★ $173.88
$75.21
AVG Volume (30 Days)
170.4K
★ 1.3M
Earning Date
10-22-2026
10-29-2026
Dividend Yield
★ 0.95%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.24
$47.65
Revenue Next Year
$5.85
$49.39
P/E Ratio
$49.49
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$119.41
$22.59
52 Week High
$190.11
$68.73

Technical Indicators

Market Signals
Indicator
FSV
TVTX
Relative Strength Index (RSI) 40.15 41.15
Support Level $122.19 $58.32
Resistance Level $146.14 $59.93
Average True Range (ATR) 3.36 2.32
MACD -0.19 -0.61
Stochastic Oscillator 25.15 17.62

Price Performance

Historical Comparison
FSV
TVTX

About FSV FirstService Corporation

FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: